RPN2, as a hopeful prognostic indicator in human gastric adenocarcinoma, is a valid biomarker to forecast the consequence of chemotherapy for terminal gastric cancer,29 Zhang et al30 reported that DDOST was one of the core genes involved in bladder cancer. This evidence concerns the gene RPN2 and urinary bladder cancer.